Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
VHIR
Menu
Pre-clinical evaluation of safety and immunogenicity of recombinant BCG expressing SIV:consv in Cynomolgus macaques. A new platform for a bivalent HIV/TB vaccine development
Close Menu
VHIR
Home
Facts & Figures
Top Stories
Highlights
eCORE
Partners and Acknowledgements
WIDER
Download Summary
VHIR Annual Report 2022